Consequences of Disclosing Clinical Trial Results: Evidence from the Food and Drug Administration Amendments Act

Thomas Bourveau, Vedran Capkun () and Yin Wang
Additional contact information
Thomas Bourveau: Columbia University - Columbia Business School, Accounting, Business Law & Taxation
Vedran Capkun: HEC Paris
Yin Wang: Singapore Management University - School of Accountancy

No 1365, HEC Research Papers Series from HEC Paris

Abstract: We examine how the U.S. Food and Drug Administration Amendments Act (FDAAA) of 2007, which requires additional disclosures regarding clinical trial results, impacts information asymmetry between the disclosing pharmaceutical firm and capital market participants, the general public, academics, and practitioners. We document a reduction in information asymmetry in capital markets. We also document an increase in adverse event and product problem complaint reports filed against the pharmaceutical firms to the FDA and a higher number of drug and medical device recalls for affected firms after the FDAAA enactment. Finally, cross-sectional analyses suggest that the increase in FDA complaint reports and recalls after the FDAAA enactment was more prominent in firms with a higher bid-ask spread decrease. Taken together, our results suggest that the FDAAA has some benefits for both investors and consumers.

Keywords: disclosure; information asymmetry; clinical trial; regulation (search for similar items in EconPapers)
JEL-codes: I18 M41 M48 (search for similar items in EconPapers)
Pages: 53 pages
Date: 2020-08-05
References: Add references at CitEc
Citations:

Downloads: (external link)
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3533305 Full text (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ebg:heccah:1365

DOI: 10.2139/ssrn.3533305

Access Statistics for this paper

More papers in HEC Research Papers Series from HEC Paris HEC Paris, 78351 Jouy-en-Josas cedex, France. Contact information at EDIRC.
Bibliographic data for series maintained by Antoine Haldemann ().